The Prevention of Second Anaphylactoid Reactions to Anaesthetic Drugs
M. McD. Fisher
openalex +1 more source
Clinical manifestations of drug reaction with eosinophilia and systemic symptoms in pediatric patients. [PDF]
Blackley S+6 more
europepmc +1 more source
Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor-Leste: A Cross-Sectional Survey. [PDF]
da Costa J+3 more
europepmc +1 more source
The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids. [PDF]
Wang S, Kang Y, He C, Jin H.
europepmc +1 more source
Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. [PDF]
Dedefo MG+4 more
europepmc +1 more source
A Diagnostic Dilemma: Daptomycin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Eosinophilic Pneumonia With Concurrent COVID-19. [PDF]
Shakour H, Mumtaz R, Abu-Samra AG.
europepmc +1 more source
Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Ramified Plaques in a Patient with Multiple Myeloma. [PDF]
Güven E, Edek YC, Tamer F, Erdem Ö.
europepmc +1 more source
Cancer-Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK Yellow Card Adverse Drug Reaction (ADR) Reporting. [PDF]
Chan SHY, Layton D, Webley S, Salek S.
europepmc +1 more source
Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS. [PDF]
Xu Y, Zhao B, He L.
europepmc +1 more source